2-Quinoxalinol
Based on 1 Customer Validation
2-Quinoxalinol (2-hydroxyquinoxaline) is a 2-hydroxylated quinoxaline that possesses photocatalytic activity and interacts with various compounds, such as antioxidant vitamins and aromatic metabolites, including neurotransmitters and the pineal hormone melatonin.
For research use only. We do not sell to patients.
- CAS No.: 1196-57-2
- Formula: C8H6N2O
- Molecular Weight:146.15
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-W002071
2-Quinoxalinecarboxylic acidAntibacterial Agent -
HY-W015672
2-MethylquinoxalineDetection Marker -
HY-W017534
Brimonidine impurity 7Drug Impurity -
HY-W041703
6-Amino-5-bromoquinoxaline -
HY-W017519R
2-Quinoxalinol (Standard)Quinoline Derivative -
HY-W017534R
Quinoxalin-6-amine (Standard) -
HY-W041533
5,6,7,8-TetrahydroquinoxalineFlavor Enhancer -
HY-20803
2,3-DihydroxyquinoxalineFluorescent Reagent -
HY-69094
6-BromoquinoxalineBiochemical Reagent -
HY-W037619
Pteridine-2,4(1H,3H)-dionePteridine Derivative -
HY-138545
4-Hydroxy-6-methylcoumarinNatural Product -
HY-W037619R
Pteridine-2,4(1H,3H)-dione (Standard)
Biological Activity
Description
Chemical Information
-
CAS No. 1196-57-2
-
Appearance Solid
-
Molecular Weight 146.15
-
Formula C8H6N2O
-
Color Off-white to light brown
-
SMILES
O=C1C=NC2=CC=CC=C2N1
-
Synonyms
Quinoxalin-2-one
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
2-Quinoxalinol Related Classifications
HY-W017519 Related Classifications
Powered by Bioz